Hi Cherie,

There are 3 or 4 oral drugs in development for RRMS. Merck is supposed to request approval for their drug sometime this year. The race is on because whomever is first will likely have a windfall in revenue.

I have not read anywhere yet what the projected cost of any of these drugs will be but you can bet that it will be very high. It won't depend on what the cost to the manufacturer is but what the market will pay for such a medication.

And you can also count on a "war" among these companies, each one trying to prove that their drug is better than the competition.

Some things in the world of MS medicine never change!

Take care.

Harry